Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress, mitochondrial dysfunction ...
N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a drug discovery company that is also investing in solar energy ...
Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress, mitochondrial dysfunction, DNA methylation instability, and genomic integrity-without relying on cyt ...
Research from NeuroQure, a biotechnology company specializing in autism spectrum disorder, has led to the development of a ...
Bipolar disorder (BD) is a major mental disorder, affecting 1% of the global population. Patients suffering from BD ...
From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...
Trial Results Support Transition into Late-Stage Development with Program Expected to be Phase 2b/3-ready in H2 2026BERLIN, GERMANY, January 29, ...
Dr. Taz Bhatia M.D., a nationally recognized integrative medicine physician, author, and founder of hol+, has partnered with nonprofit Countdown for a Cure (CFAC) to help advance awareness, education, ...
Reports New Cellular Data Demonstrating Coordinated Intracellular Zinc Increase And Iron Reduction With Telomir-Zn. Telomir Pharmaceuticals (NASDAQ: TELO) announced new cellular study results showing ...
Down in the dumps? Help might be hiding in your fridge. A new, first-of-its-kind study suggests a controversial diet could ease severe, drug-resistant depression — with improvements showing up in as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results